Precision or personalized medicine incorporates molecular markers to tailor strategies for disease detection, treatment and prevention, even before clinical signs and symptoms appear. In this growing field of genomic medicine, what might the advanced practice nurse consider?
By Ken Wysocki, PhD, FNP-BC, FAANP
Chronic obstructive pulmonary disease exerts a big strain on the healthcare system, due to the high number of hospitalizations and ED visits associated with exacerbations.
Hematuria is a common sign of bladder cancer; however, it can also be benign. The range of differential diagnoses that can cause hematuria has created confusion about beginning the diagnostic process.
New developments in the treatment of T2DM have occurred, and many providers may be unfamiliar with them. Consequently, patients may endure long periods of time with poorly-controlled diabetes, placing them at undue risk for complications.
COLUMNS & DEPARTMENTS